Sanofi/Bristol Plavix Patent Suit To Begin Against Apotex

With preliminary injunction rulings weighing in Sanofi/Bristol's favor, Apotex's defense will need to make a strong case that clopidogrel patents are invalid.

More from Archive

More from Pink Sheet